BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12269363)

  • 1. Update on the Center for Devices and Radiological Health.
    Jacobson ED
    Food Drug Law J; 2000; 55(2):185-91. PubMed ID: 12269363
    [No Abstract]   [Full Text] [Related]  

  • 2. Delegations of authority and organization; Center for Devices and Radiological Health--FDA. Final rule.
    Fed Regist; 1998 May; 63(95):27207-8. PubMed ID: 10179344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Center for Devices and Radiological health: an update.
    Donawa M
    Med Device Technol; 2001 Dec; 12(10):24, 26-7. PubMed ID: 15966141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delegations of authority and organization; Center for Biologics Evaluation and Research, Center for Devices and Radiological Health, and Center for Drug Evaluation and Research--FDA. Final rule.
    Fed Regist; 1991 Nov; 56(225):58758-9. PubMed ID: 10115699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delegations of authority and organization; Center for Devices and Radiological Health. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 1999 Feb; 64(21):4964-5. PubMed ID: 10557613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Working together to enhance the efficiency of medical product development.
    Sanhai WR
    J Nucl Med; 2008 Jun; 49(6):43N-45N. PubMed ID: 18511823
    [No Abstract]   [Full Text] [Related]  

  • 7. Looking for solid ground along the Critical Path.
    Ratner M
    Nat Biotechnol; 2006 Aug; 24(8):885-7. PubMed ID: 16900118
    [No Abstract]   [Full Text] [Related]  

  • 8. Combination products regulation at the FDA.
    Lauritsen KJ; Nguyen T
    Clin Pharmacol Ther; 2009 May; 85(5):468-70. PubMed ID: 19381151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perspectives. GOP sets its sights on Food and Drug Administration.
    Barnett AA
    Faulkner Grays Med Health; 1995 Feb; 49(8):suppl 1-4. PubMed ID: 10139918
    [No Abstract]   [Full Text] [Related]  

  • 10. Microarray data--the US FDA, industry and academia.
    Hackett JL; Lesko LJ
    Nat Biotechnol; 2003 Jul; 21(7):742-3. PubMed ID: 12833089
    [No Abstract]   [Full Text] [Related]  

  • 11. Memorandum of understanding between the Food and Drug Administration and the Defense Alliance for Advanced Medical Terminology--FDA. Notice.
    Fed Regist; 1998 Jul; 63(129):36700-6. PubMed ID: 10181056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The regulation of drugs and biologics: fifty years into the future.
    Kuhlik BN
    Food Drug Law J; 2000; 55(1):21-5. PubMed ID: 12269358
    [No Abstract]   [Full Text] [Related]  

  • 13. The U.S. medical device industry: entrepreneurs' future hinges on reforms at the Food and Drug Administration.
    Kimbell JJ
    Food Drug Law J; 1996; 51(2):339-43. PubMed ID: 11822328
    [No Abstract]   [Full Text] [Related]  

  • 14. Remarks of the Commissioner of Food and Drugs.
    Henney JE
    Food Drug Law J; 2000; 55(1):1-4. PubMed ID: 12269355
    [No Abstract]   [Full Text] [Related]  

  • 15. The impact of FDA reform.
    Trunzo J
    Med Device Technol; 2003 Apr; 14(3):36-7. PubMed ID: 12789699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Food and Drug Administration's perspectives on pediatric cardiac assist devices.
    Chen EA; Patel-Raman SM; Berman MR; Zuckerman BD
    ASAIO J; 2008; 54(2):147-9. PubMed ID: 18356646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical devices post-approval studies program: vision, strategies, challenges and opportunities.
    Marinac-Dabic D; Bonhomme M; Loyo-Berrios N; Gross T; Ciperson R; Gardner S; Marcarelli M
    Food Drug Law J; 2007; 62(3):597-604. PubMed ID: 17915402
    [No Abstract]   [Full Text] [Related]  

  • 18. A new public/private partnership in the interest of public health.
    Barlow WK
    Food Drug Law J; 1999; 54(3):363-6. PubMed ID: 11797703
    [No Abstract]   [Full Text] [Related]  

  • 19. Devising a new approach. Proposed changes to device law aim to boost funding, streamline product review.
    Rhea S
    Mod Healthc; 2007 May; 37(22):30-1. PubMed ID: 17608125
    [No Abstract]   [Full Text] [Related]  

  • 20. Of specialty interest: the Food and Drug Administration: a partner in safe practice.
    Baker K
    ORL Head Neck Nurs; 2003; 21(2):25-7. PubMed ID: 12747041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.